Toby G. Singer

Jones Day (Washington DC)
Lawyer (Partner)

Toby Singer is one of the nation’s leading authorities on mergers and other antitrust matters in the health care industry, and her practice focuses on antitrust counseling and litigation for health care clients. She represents providers and payers on a wide variety of antitrust issues, from mergers and acquisitions and other transactions to less formal alliances among competitors as well as counseling on conduct issues. She has handled numerous federal and state government investigations and has defended clients in both government and private antitrust litigation. Significant representations include CaremarkRx’s acquisition of AdvancePCS (FTC File No. 03-0239) and Sutter Health’s merger with Summit Medical Center (130 F. Supp. 2d 1109 (N.D. Cal. 2000)), as well as defending class action lawsuits against Ascension Health (Cason-Merenda v. Detroit Medical Center (E.D. Mich.) and Fleischman v. Albany Medical Center (N.D.N.Y.)). Prior to joining Jones Day, Toby served as a deputy assistant director in the Bureau of Competition of the Federal Trade Commission. Toby is a past chair of the Antitrust Practice Group of the American Health Lawyers Association, a past vice chair of the Health Care Committee of the American Bar Association Section of Antitrust Law, and is on the advisory board of BNA’s Health Law Reporter. She is a frequent speaker on antitrust subjects at American Bar Association and American Health Lawyers Association conferences and has testified at government hearings on competition in health care.

Distinctions

Linked authors

Jones Day (Washington DC)
Jones Day (Washington DC)
Jones Day (Houston)
Jones Day (Washington DC)
Jones Day (Washington DC)
Columbia University (New York)
Jones Day (Washington DC)
Jones Day (Washington DC)

Articles

5387 Bulletin

J. Bruce McDonald, Toby G. Singer The US Court of Appeals for the 7th circuit rejects an antitrust lawsuit that challenged premerger planning and information exchanges between two health insurers (Omnicare / UnitedHealth)

284

This article has been selected for the business category, mergers section of the 2012 Antitrust Writing Awards. Click here to learn more about the Antitrust Writing Awards. Last week the U.S. Court of Appeals for the Seventh Circuit rejected an antitrust lawsuit by institutional pharmacy (...)

Geoffrey D. Oliver, Michael H. Knight, Toby G. Singer The US District Court for the District of Minnesota dismisses FTC complaint seeking divestiture and disgorgement remedy in consummated acquisition in the healthcare industry (Lundbeck)

1202

In a decision that was filed under seal in late August but released publicly just last week, the U.S. District Court for the District of Minnesota dismissed with prejudice the complaint filed by the Federal Trade Commission (FTC) and the State of Minnesota challenging the already-consummated (...)

Toby G. Singer The US District Court in Ohio grants summary judgement in a class action suit alleging that a drug manufacturer’s rebates to pharmacy benefit managers to obtain an exclusive listing do not violate the Sherman Act (Wyeth / J.B.D.L)

881

A U.S. District Court in Ohio granted summary judgment for defendants in a class action suit alleging that a drug manufacturer’s rebates to pharmacy benefit managers in order to obtain an exclusive listing in the PBMs’ drug formulary violated Section 1 of the Sherman Act. The plaintiffs, (...)

Send a message